Gilead recalls Remdesivir over glass contamination
(Agency report) American biopharmaceutical company Gilead Sciences Inc. has issued a nationwide recall of two lots of its coronavirus treatment drug Remdesivir due to the “presence of glass particulates,” the company said Friday. Washington Post reported early Sunday that Remdesivir,…
Skip to content


